top of page
EIDD-1931 Oral Capsules - FIP and FCV treatment
MolnuFIP™ delivers pure EIDD-1931, the active antiviral metabolite of molnupiravir, in a formulation designed exclusively for feline physiology. By using EIDD-1931 directly—rather than modifying human molnupiravir capsules—MolnuFIP™ provides a more precise, consistent, and veterinary-appropriate approach to FIP care.
 
Purpose-Built Feline Formulation
Each MolnuFIP™  EIDD-1931 capsule contains 15 mg of EIDD-1931, equivalent in activity to approximately 66 mg of molnupiravir (EIDD-2801).
This formulation is optimized for:
 
  • Feline metabolic rate
  • Gastrointestinal absorption profile
  • Reliable dose–response performance
 
The result is accurate, predictable antiviral activity with reduced variability compared to human-intended products.
 
Proven Antiviral Potency
Published research demonstrates that:
 
  • EIDD-1931 exhibits up to 10× greater in-vitro antiviral potency compared with molnupiravir (EIDD-2801).
  • EIDD-1931 demonstrates 7.3× higher potency than GS-441524 under similar test conditions.
 
This potency advantage enables therapeutic efficacy at lower milligram doses, supporting improved tolerability and rapid clinical response.
 
Reference:
Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity Against Enterovirus Infections In Vitro and In Vivo
https://www.mdpi.com/1999-4915/14/6/1142
 
Comprehensive Support Across FIP Presentations
MolnuFIP™ is formulated to support recovery across all major forms of FIP, including:
  • Wet FIP (effusive)
  • Dry FIP (non-effusive)
  • Mixed or transitional presentations
 
Additional formulation benefits:
  • Optimized for feline metabolism and tissue penetration
  • Highly consistent blood-level performance
  • Designed to support low relapse incidence when used according to veterinary guidance
 
Precision, Safety & Confidence in Every Dose
With MolnuFIP™, your cat receives an advanced, veterinary-engineered antiviral designed for dependable performance:
 
  • Scientifically grounded formulation
  • Consistent mg-per-kg dosing
  • No need to modify human medications
  • Backed by modern antiviral research
 
Visit molnufip.com for more information

EIDD-1931 Oral Capsules - FIP and FCV treatment

Rating is 5.0 out of five stars based on 1 review
AED 149.00Price
Quantity

  • Dosage Instructions

    Administer one (1) capsule per 2.5 kg of body weight, given every 12 hours.

    Dosing Examples

    • Example 1: A 2.0 kg kitten diagnosed with the effusive (wet) form of FIP should receive one capsule every 12 hours.

    • Example 2: A 4.6 kg adult cat diagnosed with the non-effusive (dry) form of FIP should receive two capsules every 12 hours.

    Monitoring and Follow-Up

    We strongly recommend that your cat receives a complete blood panel approximately every 30 days, in conjunction with ongoing evaluation by your primary veterinarian. Regular monitoring allows your veterinarian to assess clinical response and determine whether continued treatment, dose adjustment, or discontinuation is appropriate.

Reviews

Rated 5 out of 5 stars.
5.0 | 1 review
1 review
  • RumiApr 30
    Rated 5 out of 5 stars.
    복막염진단 7개월20일 째

    주사 경구제 다시 주사...길에서 죽어가는 아이를 데리고 와 힘든 치료를 이어갔음에도 혈검수치가 좋지않아 의사가 안락사를 권유할 정도였다 마지막으로 이 약을 써보자고 했고 처음으로 혈검 결과가 좋았다

    그 사이 이사도 하고 조금 넓은 환경에서 놀게 해주었더니 원래 있던 터줏대감을 밀어낼 정도로 밝아졌다

    얼른 완치판정 받았으면..

    Was this helpful?
bottom of page